Use burden of disease to prioritise research

Diseases whose main burden is located in the lowest income regions of the world are relatively neglected in randomised controlled trials, researchers say. Research funding agencies should prioritise funding and research activities transparently, informed by such instruments as disease burden, say the international team of researchers in an analysis published in the BMJ.   Disease ...

Already a member?

Login to keep reading.

© 2021 the limbic